Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

NCT00458913 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

NETWORK

Sponsor class

Conditions

Malignant Mesothelioma

Interventions

DRUG: bortezomib
DRUG: cisplatin

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC